Novozymes
| Novozymes A / S
|
|
|---|---|
 |
|
| legal form | Aktieselskab |
| ISIN | DK0010272129 |
| Seat |
Bagsværd , Denmark
|
| management | Peder Holk Nielsen (CEO) |
| Number of employees | 6,485 |
| sales | 14 billion dkr (1.9 billion euros ) |
| Branch | biotechnology |
| Website | www.novozymes.com |
| As of December 31, 2015 | |
Novozymes A / S is a Danish biotechnology company based in Bagsværd (Denmark) adapted to Novo Holdings A / S belongs. The company is listed in the OMX Copenhagen 20 share index. Novozymes is primarily active in the research and marketing of enzymes and microorganisms. In 2000, the Novo Nordisk company was split into three independent companies, which resulted in Novozymes , among others .
The research and biotechnology company Organobalance, which was co-founded in 2001 by the Berlin microbiologists Christine Lang and Ulf Stahl , has been part of Novozymes since September 2016 . Among other things, the company has one of the world's largest collections with more than 8,000 yeast and lactic acid bacteria cultures, dating back to the 1920s.
Web links
Individual evidence
- ↑ a b Annual Report 2015 ( Memento of the original dated November 4, 2016 in the Internet Archive ) Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice.
- ↑ history. In: organobalance.de. Retrieved April 29, 2018 .
- ↑ Novozymes takes over Organobalance. In: biooekonomie.de. Retrieved April 29, 2018 .
- ↑ Lactic acid bacteria: New approach against H. pylori? In: Doctors newspaper . No. 190 , January 29, 2015, p. 7 ( aerztezeitung.de ).
